[1]
Chakraborty, P. and Chakraborty, K. 2022. Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment. European Journal of Biological Research. 12, 1 (Jan. 2022), 1-10.